Bivalirudin versus Heparin Monotherapy in Percutaneous Coronary Intervention Patients: a Comparison of Acute Adverse Outcomes and Long Term Mortality

被引:0
|
作者
Ephrem, Georges
Kim, Michael C.
Jauhar, Rajiv
Meraj, Perwaiz M.
机构
关键词
Anticoagulants; Percutaneous coronary intervention (PCI); Glycoprotein iib/iiia platelet inhibitors; Outcomes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
13072
引用
收藏
页数:4
相关论文
共 50 条
  • [1] BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION: A COMPARISON OF ACUTE ADVERSE OUTCOMES
    Meraj, Perwaiz M.
    Doshi, Rajkumar
    Patel, Amitkumar
    George, Bhavitha
    Kaur, Lakhbir
    Mozawalla, Fatima
    Bhiuya, Tanzim
    Jauhar, Rajiv
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 268 - 268
  • [2] BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST
    Ephrem, Georges
    Guenoun, Jonathan
    Kim, Michael
    Jauhar, Rajiv
    Meraj, Perwaiz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A115 - A115
  • [3] BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST
    Ephrem, Georges
    Guenoun, Jonathan
    Kim, Michael
    Jauhar, Rajiv
    Meraj, Perwaiz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A66 - A66
  • [4] Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention
    Watson, Kristin
    Seybert, Amy L.
    Saul, Melissa I.
    Lee, Joon Sup
    Kane-Gill, Sandra L.
    PHARMACOTHERAPY, 2007, 27 (05): : 647 - 656
  • [5] Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention
    Rehmani, Ahmed
    Judkins, Chris
    Lee, Edmund
    Nguyen, Michael
    Whelan, Alan
    Schultz, Carl
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [6] BIVALIRUDIN VERSUS UNFRACTIONED HEPARIN IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Farag, Mohamed
    Gorog, Diana
    Srinivasan, Manivannan
    HEART, 2015, 101 : A9 - A9
  • [7] Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
    Patel, Hitcn
    Garris, Rana
    Bhutani, Suchit
    Shah, Priyank
    Rampal, Upamanyu
    Vasudev, Rahul
    Melki, Gabriel
    Abu Ghalyoun, Bader
    Virk, Hartaj
    Bikkina, Mahesh
    Shamoon, Faycz
    CARDIOLOGY RESEARCH, 2019, 10 (05) : 278 - 284
  • [8] Comparison of Bivalirudin Monotherapy Versus Unfractionated Heparin Plus Tirofiban in Patients With Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention
    Tavano, Davide
    Visconti, Gabriella
    D'Andrea, Davide
    Focaccio, Amelia
    Golia, Bruno
    Librera, Mariateresa
    Caccavale, Mario
    Ricciarelli, Bruno
    Briguori, Carlo
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (09): : 1222 - 1228
  • [9] Bivalirudin versus heparin with primary percutaneous coronary intervention
    Venetsanos, Dimitrios
    Lawesson, Ofia Sederholm
    James, Stefan
    Koul, Sasha
    Erlinge, David
    Swahn, Eva
    Alfredsson, Joakim
    AMERICAN HEART JOURNAL, 2018, 201 : 9 - 16
  • [10] Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention
    Centurion, Osmar Antonio
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2016, 10 : 122 - 129